Skip to content

Remote Ischemic Conditioning for Motor Recovery After Acute Ischemic Stroke

The Safety and Efficacy of Remote Ischemic Conditioning on Motor Recovery After Acute Stroke

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05263531
Enrollment
20
Registered
2022-03-02
Start date
2021-12-31
Completion date
2023-01-31
Last updated
2022-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Stroke

Keywords

remote ischemic conditioning

Brief summary

The most recent treatment for stroke rehabilitation is to combine physical training with other therapies to enhance or accelerate recovery.The hypothesis of this study is that remote ischemic conditioning (RIC) might have a beneficial effect on motor recovery of AIS

Detailed description

Despite the effective reperfusion therapies ,acute ischemic stroke(AIS) is still one of the leading causes of disability, resulting in an economic burden. Multidisciplinary rehabilitation has benefit effects on motor recovery and remains the first-line intervention strategy for attenuating motor function impairments. However, the effect of the physiotherapy application alone is not satisfactory, The potential treatment effect of RIC on motor recovery of AIS has not been investigated. The investigators designed this randomized clinical trial to examine whether RIC has a beneficial effect on poststroke motor function recovery.There are 2 arms in this trial: One arm is RIC treatment, the other one is sham RIC treatment. The motor function will be assessed by Fugl-Meyer Motor Scale before and after the treatment to evaluate its exact effect on motor recovery.

Interventions

DEVICEremote ischemic conditioning

RIC is a physical strategy performed by an electric autocontrol device with cuffs placed on bilateral arms and inflated to design pressure for 5-min followed by deflation for 5-min, the procedures is performed repeatedly for 5 times.

Sponsors

Ji Xunming,MD,PhD
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Subjects aged 18-80 years; 2. First-ever unilateral ischemic stroke,5\ 10 days after onset; 3. Had motor dysfunction caused by stroke(Fugl-Meyer≤55) 4. mRS≤1 before stroke 5. NIHSS 6\ 20 6. Written consent was obtained from the subject.

Exclusion criteria

1. Cannot complete assessments-ie, psychiatric disorders, sensory aphasia, dementia 2. brainstem lesion or cerebellun lesion 3. poorly controlled diabetes mellitus 4. Application of agent which thought to impair or improve recovery based on laboratory and clinical evidence within 1 month (ie,DA,MAOI, SSRI,α1/α2 adrenergic receptor inhibitors,BZD,etc) 5. severe soft tissue injury, fracture, or peripheral vascular disease in the upper limbs.

Design outcomes

Primary

MeasureTime frameDescription
changes in Fugl-Meyer score0-3 monthsFugl-Meyer scale assessment (FMA) will be used for assessing improvement of motor function. Total score of FMA range from 0 to 100, a score of 100 means full recovery of motor function

Secondary

MeasureTime frameDescription
changes in Barthel Index0-3monthsBarthel Index will be used for assessing ability of daily life, range from 0 to 100, the higher the score, the better recovery patient reach
Changes of the level of angiogenesis related factors0-3 monthscirculatory VEGF,EGF,PDGF,CD40L will be tested before and after the treatment

Countries

China

Contacts

Primary ContactXunming Ji, MD PhD
jixunming@vip.163.com011-86-10-8319-8952
Backup ContactWantong Yu, MD
422189034@qq.com861013552260818

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026